These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22450745)

  • 1. Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer.
    Saito R; Shirakawa R; Nishiyama H; Kobayashi T; Kawato M; Kanno T; Nishizawa K; Matsui Y; Ohbayashi T; Horiguchi M; Nakamura T; Ikeda T; Yamane K; Nakayama E; Nakamura E; Toda Y; Kimura T; Kita T; Ogawa O; Horiuchi H
    Oncogene; 2013 Feb; 32(7):894-902. PubMed ID: 22450745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ral GTPase Activation by Downregulation of RalGAP Enhances Oral Squamous Cell Carcinoma Progression.
    Gao P; Liu S; Yoshida R; Shi CY; Yoshimachi S; Sakata N; Goto K; Kimura T; Shirakawa R; Nakayama H; Sakata J; Kawashiri S; Kato K; Wang XY; Horiuchi H
    J Dent Res; 2019 Aug; 98(9):1011-1019. PubMed ID: 31329042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of RalGTPase-Activating Protein Promotes Colitis-Associated Cancer via NLRP3 Inflammasome Activation.
    Iida T; Hirayama D; Minami N; Matsuura M; Wagatsuma K; Kawakami K; Nagaishi K; Nojima M; Ikeuchi H; Hirota S; Shirakawa R; Horiuchi H; Nakase H
    Cell Mol Gastroenterol Hepatol; 2020; 9(2):277-293. PubMed ID: 31622786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma.
    Yoshimachi S; Shirakawa R; Cao M; Trinh DA; Gao P; Sakata N; Miyazaki K; Goto K; Miura T; Ariake K; Maeda S; Masuda K; Ishida M; Ohtsuka H; Unno M; Horiuchi H
    Cancer Sci; 2021 Aug; 112(8):3064-3073. PubMed ID: 34009715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer.
    Atala A
    J Urol; 2013 Oct; 190(4):1437. PubMed ID: 24029362
    [No Abstract]   [Full Text] [Related]  

  • 6. Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis.
    Uegaki M; Kita Y; Shirakawa R; Teramoto Y; Kamiyama Y; Saito R; Yoshikawa T; Sakamoto H; Goto T; Akamatsu S; Yamasaki T; Inoue T; Suzuki A; Horiuchi H; Ogawa O; Kobayashi T
    Carcinogenesis; 2019 Dec; 40(12):1535-1544. PubMed ID: 31058283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms.
    Vigil D; Martin TD; Williams F; Yeh JJ; Campbell SL; Der CJ
    J Biol Chem; 2010 Nov; 285(45):34729-40. PubMed ID: 20801877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells.
    Kim CJ; Yoshioka N; Tambe Y; Kushima R; Okada Y; Inoue H
    Int J Cancer; 2005 Oct; 117(1):51-8. PubMed ID: 15880581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-mediated silencing of Dlg5 facilitates bladder cancer metastasis.
    Zhou Z; Guo Y; Liu Y; Zhang F; Wang Y; Shen B; Qin Y; Qiu J
    Exp Cell Res; 2015 Feb; 331(2):399-407. PubMed ID: 25478998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
    Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
    Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.
    Lim KH; O'Hayer K; Adam SJ; Kendall SD; Campbell PM; Der CJ; Counter CM
    Curr Biol; 2006 Dec; 16(24):2385-94. PubMed ID: 17174914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase protein and gene expression in bladder cancer.
    Gohji K; Okamoto M; Kitazawa S; Toyoshima M; Dong J; Katsuoka Y; Nakajima M
    J Urol; 2001 Oct; 166(4):1286-90. PubMed ID: 11547059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.
    Maas S; Warskulat U; Steinhoff C; Mueller W; Grimm MO; Schulz WA; Seifert HH
    Urology; 2004 Feb; 63(2):392-7. PubMed ID: 14972509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
    Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
    Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.
    Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY
    Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
    Zhang H; Jiang H; Wang W; Gong J; Zhang L; Chen Z; Ding Q
    Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant role of E-cadherin in the progression of bladder cancer.
    Imao T; Koshida K; Endo Y; Uchibayashi T; Sasaki T; Namiki M
    J Urol; 1999 Feb; 161(2):692-8. PubMed ID: 9915485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.